NO975409L - <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse - Google Patents

<Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse

Info

Publication number
NO975409L
NO975409L NO975409A NO975409A NO975409L NO 975409 L NO975409 L NO 975409L NO 975409 A NO975409 A NO 975409A NO 975409 A NO975409 A NO 975409A NO 975409 L NO975409 L NO 975409L
Authority
NO
Norway
Prior art keywords
depart
variants
nucleotide sequences
nucleotide
sequences
Prior art date
Application number
NO975409A
Other languages
English (en)
Norwegian (no)
Other versions
NO975409D0 (no
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO975409L publication Critical patent/NO975409L/no
Publication of NO975409D0 publication Critical patent/NO975409D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO975409A 1995-06-01 1997-11-25 <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse NO975409D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations
PCT/FR1996/000802 WO1996038556A2 (fr) 1995-06-01 1996-05-29 Deltap62, ses variants, sequences d'acides nucleiques les codant, et leurs utilisations en therapie genique anti-cancereuse

Publications (2)

Publication Number Publication Date
NO975409L true NO975409L (no) 1997-11-25
NO975409D0 NO975409D0 (no) 1997-11-25

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975409A NO975409D0 (no) 1995-06-01 1997-11-25 <Delta>P62, varianter derav, nukleinsekvenser og deres anvendelse

Country Status (15)

Country Link
US (1) US6544948B1 (sk)
EP (1) EP0828832A2 (sk)
JP (1) JPH11506325A (sk)
KR (1) KR19990022193A (sk)
AU (1) AU718889B2 (sk)
BR (1) BR9608632A (sk)
CA (1) CA2219861A1 (sk)
CZ (1) CZ291533B6 (sk)
FR (1) FR2734826B1 (sk)
HU (1) HUP9901346A3 (sk)
IL (1) IL118493A0 (sk)
NO (1) NO975409D0 (sk)
SK (1) SK283071B6 (sk)
WO (1) WO1996038556A2 (sk)
ZA (1) ZA964392B (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040606A2 (en) * 1999-01-06 2000-07-13 The Regents Of The University Of California Modulation of hiv replication using sam68
US7479368B2 (en) * 2001-07-30 2009-01-20 G.R.M.O. (Groupe De Recherche En Maladies Osseuses) Inc. Method for detecting subjects having Paget's disease of bone
AU2012294454B2 (en) * 2011-08-08 2017-02-02 Curelab Oncology, Inc. Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
WO1995002697A1 (fr) * 1993-07-13 1995-01-26 Rhone-Poulenc Rorer S.A. Vecteurs adenoviraux defectifs et utilisation en therapie genique

Also Published As

Publication number Publication date
FR2734826B1 (fr) 1997-07-04
CZ375997A3 (cs) 1998-02-18
AU6129196A (en) 1996-12-18
CZ291533B6 (cs) 2003-03-12
JPH11506325A (ja) 1999-06-08
HUP9901346A3 (en) 2000-10-30
MX9708877A (es) 1998-03-31
ZA964392B (en) 1996-12-09
IL118493A0 (en) 1996-09-12
BR9608632A (pt) 1999-05-04
WO1996038556A2 (fr) 1996-12-05
HUP9901346A2 (hu) 1999-08-30
CA2219861A1 (fr) 1996-12-05
WO1996038556A3 (fr) 1997-01-09
KR19990022193A (ko) 1999-03-25
EP0828832A2 (fr) 1998-03-18
AU718889B2 (en) 2000-04-20
US6544948B1 (en) 2003-04-08
SK283071B6 (sk) 2003-02-04
SK161397A3 (en) 1998-07-08
FR2734826A1 (fr) 1996-12-06
NO975409D0 (no) 1997-11-25

Similar Documents

Publication Publication Date Title
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
DE69840172D1 (de) Rna exportelement
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO975419D0 (no) Gen-svitsj omfattende en ecdysonreseptor
DE69632760D1 (de) Ostomiekupplung
DE69428043D1 (de) Pre-keramische silikon-polymere
DK1019358T3 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
ATE291038T1 (de) Polymerisationsverfahren
FI964423A0 (fi) DNA-sekvenssit
BR9401355A (pt) Oligonucleotídeo e nucleotídeo.
AU6244296A (en) Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof
ID21013A (id) Deret nukleotida antipeka
DK0737456T3 (da) Ostomikobling
NO982701D0 (no) Polymerisasjonskatalysatorer og fremgangsmÕter derav
DE69606691D1 (de) Silikonhaltige Blockcopolymere
NO20005502D0 (no) Polymerer og deres anvendelse
ATE386058T1 (de) Polymerisationsverfahren
NO975409L (no) &lt;Delta&gt;P62, varianter derav, nukleinsekvenser og deres anvendelse
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse
ATE278716T1 (de) Polymerisationsverfahren
NO20003128D0 (no) Nye p-aminofenylderivater og deres anvendelse
IT242732Y1 (it) Attacco ortodontico
NO972973D0 (no) Renseanlegg
NO982242D0 (no) Heparinanaloge kopolymerer, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application